Comparative analysis of the expression of ERBIN and Erb-B2 in normal human skin and cutaneous carcinomas

British Journal of Dermatology

Volumn 152, Issue 6, 2005, Pages 1248-1255

  Lebeau, S ^a   Masouye I ^a   Berti, M ^a   Augsburger, E ^a   Saurat, J H ^a   Borradori, L ^a   Fontao, Lionel ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Basal cell carcinoma; Erb B family; Erb B2; ERBIN; Keratoacanthoma; Squamous cell carcinoma

Indexed keywords

BINDING PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBIN; PROTEIN ANTIBODY; RAS PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE; CELL POLARITY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; KERATOACANTHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SWEAT GLAND; TISSUE DISTRIBUTION; TISSUE SECTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL LINE; CELL MEMBRANE; CYTOSOL; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KERATINOCYTES; RECEPTOR, ERBB-2; SKIN; SKIN NEOPLASMS;

EID: 21644476291     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06687.x     Document Type: Article

References (28)

1. Boni R, Schuster C, Nehrhoff B, Burg G. Epidemiology of skin cancer. Neuroendocrinol Lett 2002; 23(Suppl. 2): 48-51.
2. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411:342-8.
3. Krahn G, Leiter U, Kaskel P et al. Coexpression patterns of EGFR, HER2, HER3 and HER4 in non-melanoma skin cancer. Eur J Cancer 2001; 37:251-9.
4. Cook PW, Piepkorn M, Clegg CH et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Invest 1997; 100:2286-94.
5. Dominey AM, Wang XJ, King LE Jr et al. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ 1993; 4:1071-82.
6. Vassar R, Fuchs E. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev 1991; 5:714-27.
7. Hudson LG, McCawley LJ. Contributions of the epidermal growth factor receptor to keratinocyte motility. Microsc Res Tech 1998; 43:444-55.
8. Wells A. Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 2000; 78:31-101.
9. Olayioye MA, Neve RM, Lane HA, Hynes NE. The ErbB signaling network: receptor heterodimerization in development and cancer. EMBO J 2000; 19:3159-67.
10. Stoll SW, Kansra S, Peshick S et al. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes. Neoplosia 2001; 3:339-50.
11. Piepkorn M, Predd H, Underwood R, Cook P. Proliferation-differentiation relationships in the expression of heparin-binding epidermal growth factor-related factors and erbB receptors by normal and psoriatic human keratinocytes. Arch Dermatol Res 2003; 295:93-101.
12. Maguire HC Jr, Jaworsky C, Cohen JA et al. Distribution of neu (c-erbB-2) protein in human skin. J Invest Dermatol 1989; 92:786-90.
13. Aimed NU, Ueda M, Ichihashi M. Increased level of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinoma. Br J Dermatol 1997; 136:908-12.
14. Suo Z, Su W, Holm R, Nesland JM. Lack of expression of c-erbB-2 oncoprotein in human esophageal squamous cell carcinomas. Anticancer Res 1995; 15:2797-8.
15. Bol D, Kiguchi K, Beltran L et al. Severe follicular hyperplasia and spontaneous papilloma formation in transgenic mice expressing the neu oncogene under the control of the bovine keratin 5 promoter. Mol Carcinog 1998; 21:2-12.
16. Xie W, Wu X, Chow LT et al. Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles. Cell Growth Differ 1998; 9:313-25.
17. Borg JP, Marchetto S, Le Bivic A et al. ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor. Nat Cell Biol 2000; 2:407-14.
18. Favre B, Fontao L, Koster J et al. The hemidesmosomal protein bullous pemphigoid antigen 1 and the integrin beta 4 subunit bind to ERBIN. Molecular cloning of multiple alternative splice variants of ERBIN and analysis of their tissue expression. J Biol Chem 2001; 276:32427-36.
19. Huang YZ, Wang Q, Xiong WC, Mei L. Erbin is a protein concentrated at postsynaptic membranes that interacts with PSD-95. J Biol Chem 2001; 276:19318-26.
20. Saito H, Santoni MJ, Arsanto JP et al. Lano, a novel LAP protein directly connected to MAGUK proteins in epithelial cells. J Biol Chem 2001; 276:32051-5.
21. Izawa I, Nishizawa M, Tomono Y et al. ERBIN associates with p0071, an armadillo protein, at cell-cell junctions of epithelial cells. Genes Cells 2002; 7:475-85.
22. Jaulin-Bastard F, Saito H, Le Bivic A et al. The ERBB2/HER1 receptor differentially interacts with ERBIN and PICK1 PSD-95/DLG/ZO-1 domain proteins. J Biol Chem 2001; 276:15256-63.
23. Huang YZ, Zang M, Xiong WC et al. Erbin suppresses the MAP kinase pathway. J Biol Chem 2003; 278:1108-14.
24. Lever WF, Schaumburg-Lever G. Histopathology of the Skin, 7th edn. Philadelphia: Lippincott-Raven, 1990.
25. Gomez M, Navarro P, Quintanilla M, Cano A. Expression of alpha 6 beta 4 integrin increases during malignant conversion of mouse epidermal keratinocytes: association of beta 4 subunit to the cytokeratin fraction. Exp Cell Res 1992; 201:250-61.
26. Fontao L, Dirrig S, Owaribe K et al. Polarized expression of HD1: relationship with the cytoskeleton in cultured human colonic carcinoma cells. Exp Cell Res 1997; 231:319-27.
27. Sollberg S, Peltonen J, Uitto J. Differential expression of laminin isoforms and beta 4 integrin epitopes in the basement membrane zone of normal human skin and basal cell carcinomas. J Invest Dermatol 1992; 98:864-70.
28. Stanley JR, Beckwith JB, Fuller RP, Katz SI. A specific antigenic defect of the basement membrane is found in basal cell carcinoma but not in other epidermal tumors. Cancer 1982; 50:1486-90.